Rare Diseases Report 2023

A new chapter for research on treating Huntington’s disease


 

References

1. Genentech. Genentech Provides Update on Tominersen Program in Manifest Huntington’s Disease. https://www.gene.com/media/press-releases/14902/2021-03-22/genentech-provides-update-on-tominersen-.

2. Wave Life Sciences. Defining a new era of oligonucleotides. https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-positive-update-phase-1b2a-select.

3. Novartis. Community update: Status of VIBRANT-HD, the study of branaplam/LMI070 in Huntington’s disease. https://hdsa.org/wp-content/uploads/2022/08/Novartis-FINAL-Community-Letter-8-24-22.pdf.

4. UniQure. Second Quarter 2022 Financial Results. https://uniqure.gcs-web.com/node/10856/pdf.

5. Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. Cell. 2015 Jul 30;162(3):516-26. doi: 10.1016/j.cell.2015.07.003.

6. Moss DJH et al. Lancet Neurol. 2017 Sep;16(9):701-11. doi: 10.1016/S1474-4422(17)30161-8.

7. CHDI Foundation. Postcard from Dubrovnik 2023. https://chdifoundation.org/postcard-from-dubrovnik-2023/.

Pages

Recommended Reading

Study compares noninvasive treatments of cutaneous neurofibromas
MDedge Neurology
FDA gives fast-track approval to new ALS drug
MDedge Neurology
U.S. incidence, prevalence of myasthenia gravis is rising
MDedge Neurology
FDA OKs new drug for Fabry disease
MDedge Neurology
Can a repurposed Parkinson’s drug slow ALS progression?
MDedge Neurology
Myasthenia gravis drug gets FDA nod
MDedge Neurology
Gene therapy promising for reversal of hereditary vision loss
MDedge Neurology
West Nile infections rising in the U.S.
MDedge Neurology
Emerging therapies in Duchenne and facioscapulohumeral muscular dystrophy
MDedge Neurology
Has prompt diagnosis of amyotrophic lateral sclerosis become urgent?
MDedge Neurology